SNY
$46.11
Revenue | $22883Mn |
Net Profits | $1970Mn |
Net Profit Margins | 8.61% |
PE Ratio | 20.19 |
Sanofi’s revenue jumped 99.75% since last year same period to $22883Mn in the Q4 2023. On a quarterly growth basis, Sanofi has generated 80.21% jump in its revenue since last 3-months.
Sanofi’s net profit fell -36.68% since last year same period to $1970Mn in the Q4 2023. On a quarterly growth basis, Sanofi has generated -21.98% fall in its net profits since last 3-months.
Sanofi’s net profit margin fell -68.3% since last year same period to 8.61% in the Q4 2023. On a quarterly growth basis, Sanofi has generated -56.71% fall in its net profit margins since last 3-months.
Sanofi’s price-to-earnings ratio after this Q4 2023 earnings stands at 20.19.
EPS Estimate Current Quarter | 0.95 |
EPS Estimate Current Year | 0.95 |
Sanofi’s earning per share (EPS) estimates for the current quarter stand at 0.95 - a -36.47% fall from last quarter’s estimates.
Sanofi’s earning per share (EPS) estimates for the current year stand at 0.95.
Earning Per Share (EPS) | 0 |
Sanofi’s earning per share (EPS) fell -100% since last year same period to 0 in the Q1 2024. This indicates that the Sanofi has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2024-04-25 | 0.95 | 0 | -100% |